Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

17th China International Peptide Academic Symposium

Events
17th China International Peptide Academic Symposium

Last week we attended the 17th China International Peptide Academic Symposium hosted by Nankai University in Tianjin. The focus of this year’s Symposium was “Peptides: Innovative Applications, Smart Future”.

Our CEO, Meritxell Teixidó, was invited to participate in the symposium and deliver a Keynote Lecture on “Gate2Brain Blood-Brain Barrier Shuttle Peptides, From Discovery to Applications”.

During this immersive and rewarding visit, we had the privilege of witnessing an exceptional display of groundbreaking advancements and discoveries in the realm of peptides and related disciplines from across the globe. We had the chance to observe the remarkable contributions made by distinguished experts and scholars and engage in meaningful exchanges with the vibrant peptide community.

Getting acquainted with the Chinese peptide scientific community has been an exceptional experience. We were warmly welcomed and the organization made our visit remarkable. Furthermore, we had the privilege of exploring renowned landmarks such as the Great Wall and the Forbidden City. Both standing as monumental barriers!
Gate2Brain, bringing medicines beyond barriers.
June 19, 2023/by noticias
Tags: peptides, symposium
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/06/xina-g2b.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-06-19 09:15:142023-06-19 09:29:4417th China International Peptide Academic Symposium
You might also like
GORDON CONFERENCESgate2brainGordon Research Conferences
New Trends in Brain Shuttle Peptides
Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma
Back to Work with Peptides
Gate2Brain: the startup that delivers drugs to the brain to treat childhood cancer with no cure
Imitating nature to improve health
Tides 2023G2BTides USA 2023 Oligonucleotide & Peptide Therapeutic
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Frontiers of Innovation and EntrepreneurshipFrontiers of Innovation and EntrepreneurshipG2BBits & PretzelsG2BBits & Pretzels
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}